Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL618776 | 0.87 | MMP2 (0.40) | CYP3A4TDP1MMP2 | |
| Iodide SCHEMBL7778537 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL7641328 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL10601355 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL11676491 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL15193635 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL11614732 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL11614727 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL809369 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL4444588 | 0.76 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-03 | — | — | US | disclosed |
| CN-102822185-A | Thin film and compound used in the same | SUMITOMO CHEMICAL CO | 2012-12-12 | — | — | CN | disclosed |
| CN-102414178-A | Metal complex having aromatic ligand that contains nitrogen atom | SUMITOMO CHEMICAL CO | 2012-04-11 | — | — | CN | disclosed |
| EP-2423192-A1 | METAL COMPLEX HAVING AROMATIC LIGAND THAT CONTAINS NITROGEN ATOM | Sumitomo Chemical Company, Limited (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | MICA, CD4, CLTC | CYP3A4 4299/4885TDP1 4839/4885ESR1 1525/4885 |
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | NR2E3, NR3C1, NR0B2 | CYP3A4 1842/4885TDP1 4067/4885ESR1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.